Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
69
NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 15, 2019
Completion: Nov 2, 2028
NCT04323657
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
Start: Mar 27, 2020
Completion: Feb 24, 2023
NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
Start: Jun 21, 2022
Completion: Oct 30, 2028